Shuang Feng

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

T. Liang, Y. Mao, Leida Zhang, 2022, Liver Cancer.

Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapy

Jianping Cao, Li-li Wang, Ting Wang, 2022, Radiation Medicine and Protection.

Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis.

W. Lau, Shuqun Cheng, Wei-xing Guo, 2020, Hepatobiliary surgery and nutrition.

Efficacy of Stereotactic Body Radiation Therapy in Patients With Pd-1 Inhibitor–transarterial Chemoembolization Refractory Intermediate-stage Hepatocellular Carcinoma: a Retrospective Controlled Study

Y. Zheng, Kang Wang, Shuqun Cheng, 2021 .

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase 2 trial.

Kang Wang, Jie Shi, Wei-xing Guo, 2022, Future oncology.

Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial

Wei-xing Guo, Jie Shi, Wanyee Lau, 2022, Hepatology International.